AJMC® in the Press, March 29, 2024

Frequent Primary Care Visits May Lower Costs for Higher-Risk Commercially Insured Adults

An eHealth survey revealed widespread confusion, low awareness of 2026 Medicare plan changes, and growing interest in artificial intelligence support.

Delivering Ambulatory Care in a Complex Academic Health System: Timothy W. Cutler, PharmD

Tory M. Wolff, MBA, discusses his study showing that frequent routine primary care visits may lower costs for higher-risk commercially insured adults.

Listen

AJMC Q&A with Timothy W. Cutler, PharmD | Image Credit: © UC Davis

Dr Anders Kolb on Leading Blood Cancer United Into a New Era

Timothy W. Cutler, PharmD, associate chief of ambulatory care at UC Davis Health, describes how pharmacy services patients healthy and out of the hospital.

September 25th 2025

Weighing Osimertinib vs Amivantamab-Lazertinib in Frontline EGFR NSCLC: Danny Nguyen, MD

Blood Cancer United, formerly Leukemia & Lymphoma Society, aims to enhance awareness and support for blood cancer patients during Blood Cancer Awareness Month.

Listen

AJMC Q&A with Danny Nguyen, MD | Background image credit: ipopba - stock.adobe.com

White House, Pfizer Reach Agreement on Drug Discounts; Trump Announces TrumpRx

Amivantamab plus lazertinib enhances survival in NSCLC but requires complex care compared with osimertinib, explained Danny Nguyen, MD, of City of Hope.

Orange pill bottle filled with money | Image credit: Mark Aplet - stock.adobe.com

Most Medicare Beneficiaries Find Plan Shopping Confusing, Survey Finds

The Trump administration advances the Most Favored Nation order by partnering with Pfizer, which came to the table voluntarily and has been granted a reprieve from upcoming drug tariffs.

Related Content

Frequent Primary Care Visits May Lower Costs for Higher-Risk Commercially Insured Adults

An eHealth survey revealed widespread confusion, low awareness of 2026 Medicare plan changes, and growing interest in artificial intelligence support.

Delivering Ambulatory Care in a Complex Academic Health System: Timothy W. Cutler, PharmD

Tory M. Wolff, MBA, discusses his study showing that frequent routine primary care visits may lower costs for higher-risk commercially insured adults.

Listen

Dr Anders Kolb on Leading Blood Cancer United Into a New Era

Timothy W. Cutler, PharmD, associate chief of ambulatory care at UC Davis Health, describes how pharmacy services patients healthy and out of the hospital.

September 25th 2025

Weighing Osimertinib vs Amivantamab-Lazertinib in Frontline EGFR NSCLC: Danny Nguyen, MD

Blood Cancer United, formerly Leukemia & Lymphoma Society, aims to enhance awareness and support for blood cancer patients during Blood Cancer Awareness Month.

Listen

White House, Pfizer Reach Agreement on Drug Discounts; Trump Announces TrumpRx

Amivantamab plus lazertinib enhances survival in NSCLC but requires complex care compared with osimertinib, explained Danny Nguyen, MD, of City of Hope.